Previous 10 | Next 10 |
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") is pleased to comment on its financial results for the nine months ended December 31, 2023. During the nine months ended December 31, 2023, the Company genera...
2024-02-14 13:27:48 ET Summary Edwards Lifesciences achieved 13% organic revenue growth and received FDA approval for their EVOQUE tricuspid valve replacement system. The company plans to spin off its low-growth Critical Care business to focus on the rapidly expanding structural h...
2024-02-12 16:09:46 ET Despite the challenges posed by COVID-19 and macroeconomic headwinds, the company achieved positive revenue growth in 2023. Net sales increased by $622.4 million compared to the previous year, driven by sales growth of their TAVR products. Although the gross profit incr...
2024-02-06 21:05:23 ET Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Conference Call February 06, 2024, 05:00 PM ET Company Participants Mark Wilterding - Investor Relations and Treasurer Bernard Zovighian - Chief Executive Officer Scott Ullem - Chief Fi...
2024-02-06 16:20:14 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Edwards Lifesciences Q4 2023 Earnings Preview Edwards stock jumps 8% on FDA appro...
Algoma Steel Group Inc. (ASTL) is expected to report for Q3 2024 CTS Corporation (CTS) is expected to report for Q4 2023 Xylem Inc. New (XYL) is expected to report $0.96 for Q4 2023 TIM S.A. American Depositary Shares (Each representing 5) (TIMB) is expected to report for Q4 2023 ...
2024-02-06 01:10:00 ET Summary Some big tech results fizzled, but there were two standouts last week. Nine S&P 500® companies have outlier earnings dates this week - MCD, IEX, EW, MAA, MCK, HSY, COP, TROW, CTLT. 1,558 companies are expected to report during the second...
2024-02-05 17:05:31 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Seeking Alpha’s Quant Rating on Edwards Lifesciences Read the full artic...
2024-02-02 12:20:25 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Edwards gets FDA okay for Evoque tricuspid valve replacement system Edwards Lifes...
2024-02-02 10:51:42 ET More on Edwards Lifesciences Edward Lifesciences: Still Not A Buy But Getting Closer Edwards Lifesciences: Undervalued With A Substantial Upside Potential Edwards Lifesciences provides 2024 outlook, OKs additional $1B stock buyback Edwa...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
2024-05-18 06:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
On Monday, U.S. heart valve manufacturer Edwards Lifesciences Corporation (NYSE:EW) faced an EU antitrust complaint from Indian competito...
Edwards Lifesciences today announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed to extend the valve’s durability.* Edwards’ SAPIEN 3 Ultra...